Greek Pharmacist License common mistakes
Greek Pharmacist License · Understand the traps and how to avoid them.
When asked to compare two structurally related drugs (e.g., two statins, two macrolides, two benzodiazepines), the candidate names the class and a general mechanism but cannot point to the exact structural feature that differentiates them - the extra hydroxyl, the ring size, the lipophilic side chain - and therefore cannot predict the difference in lipophilicity, metabolism, or duration of action.
Most candidates memorize drug names and indications from clinical lists, then treat medicinal chemistry as a separate subject. Because Greek university exams often test structure–activity relationships explicitly, the candidate recognizes the molecule in a picture but has never practised converting a structure into a pharmacokinetic consequence. Under time pressure they fall back on the class label, which feels like an answer.
What to do instead
Build a one-page SAR table per class before the exam: molecule, key functional group, logP implication, main metabolic route (CYP isoform or Phase II), active metabolite yes/no, half-life. Practise the reverse direction too: given a property (e.g., 'long half-life, lipophilic, CNS-penetrant'), name the structural reason. Redraw each structure from memory twice, labelling the group that matters.
The candidate identifies a crude drug or plant extract by its Greek or common name and lists one or two constituents, but cannot state the correct botanical family, the plant part used, or the characteristic marker compound used for standardisation - and mixes up morphologically similar species (e.g., different Apiaceae fruits, different Lamiaceae leaves, foxglove-type cardiac glycoside sources).
Pharmacognosy is often revised from summary tables in which family, part, and marker are compressed into one cell. Candidates learn the headline active constituent (e.g., 'digoxin from Digitalis lanata') but not the surrounding identification framework. Because the Greek market and exam include many Mediterranean aromatic and medicinal plants, similar-looking species are a natural trap.
What to do instead
Create a three-column recall sheet per drug: (1) Latin binomial and family, (2) official plant part and drying/collection note, (3) marker constituent and pharmacopoeial assay. Then practise discrimination pairs explicitly - for each confusable pair, write the one morphological or chemical test that separates them. Include at least the cardiac glycoside, alkaloid, essential-oil, and mucilage/gum groups.
When asked to design or evaluate a formulation, the candidate chooses excipients and a dosage form by habit ('tablets, use lactose and magnesium stearate') without linking the choice to the drug's Biopharmaceutics Classification System (BCS) class, solubility, stability, or the intended release profile, and without noticing incompatibilities (e.g., a reducing sugar with an amine drug, a basic drug with an acidic enteric polymer).
Formulation is taught as a list of excipient functions, so the candidate reproduces functions rather than reasoning from drug properties. Exam questions that give a drug's pKa, solubility, and stability profile are answered with a generic tablet formula because the candidate has not internalized the decision sequence: properties → route → release → excipients → process.
What to do instead
Memorize and rehearse a fixed decision chain: aqueous solubility and permeability (BCS class) → required release (immediate, modified, enteric) → route and dose → compatibility screen → excipient selection → manufacturing route. Practise with three named drugs per BCS class and justify each excipient in one sentence. Keep a short 'incompatibility list' (amine + lactose, ester + alkaline pH, hygroscopic drug + humid granulation) and check it explicitly in every practice answer.
In compounding and pharmaceutical technology calculations, the candidate sets up the arithmetic correctly but fails on unit conversion, density versus specific gravity, displacement value for suppositories, or percentage strength conventions (% w/w versus % w/v), and does not perform a final plausibility check on the result.
Calculation errors are rarely conceptual; they come from mixed units (mg versus g, mL versus L, mg/mL versus % w/v), from treating a displacement value as a dilution factor, and from working too fast under exam time pressure. Candidates also skip the sanity check because they are relieved to have produced a number at all.
What to do instead
Adopt a written template for every calculation: state the formula, convert all quantities to base units before substituting, carry units through the arithmetic, and finish with an explicit plausibility sentence ('this is 2 g in a 10 g suppository base, which is feasible'). Drill displacement-value and percentage-strength problems in sets of ten until the template is automatic, and always re-derive one value by a second route when time allows.
The candidate describes a drug's mechanism of action correctly but cannot connect it to the expected adverse effect, the contraindication, or the monitoring parameter - for example, naming beta-blockade without linking it to bronchospasm and bradycardia, or naming ACE inhibition without linking it to hyperkalaemia, cough, and angioedema risk.
Pharmacology is revised as mechanisms and pharmacotherapy as guidelines, in separate sittings. The candidate therefore holds two disconnected knowledge sets and, when asked 'what would you monitor and why', produces a monitoring list from memory of a guideline rather than deriving it from the receptor or enzyme being modulated. Derived answers are more robust and are what examiners reward.
What to do instead
For each major drug class write a single chain: target → physiological consequence → therapeutic effect → predictable adverse effects → contraindications → monitoring parameter. Then practise deriving the chain aloud from the target only. Prioritize classes where the chain is examinable: beta-blockers, ACE inhibitors/ARBs, diuretics, anticoagulants, corticosteroids, NSAIDs, aminoglycosides, and antipsychotics.
Faced with a clinical scenario, the candidate answers with the first-line drug for the disease label but ignores the patient-specific modifiers in the stem - renal or hepatic impairment, pregnancy or lactation, age, interacting co-medication, allergy - and so recommends a drug that is contraindicated or needs dose adjustment for that particular patient.
Candidates study therapy by disease chapter, so the disease name triggers a memorized first-line answer before the modifiers are processed. Exam stems deliberately bury these modifiers in a single clause. The candidate reads for the diagnosis and skims the rest, which is exactly the opposite of safe prescribing behaviour.
What to do instead
Read each scenario twice: first pass to extract the problem list and every modifier (age, renal function, hepatic function, pregnancy, allergies, current medicines), second pass to select therapy. Before finalizing, run a fixed checklist: is the drug contraindicated by any modifier, does the dose need adjustment, is there an interaction, and what monitoring is required. Write the checklist out in practice until it is applied without prompting.
In counselling and dispensing questions, the candidate gives correct pharmacological information but omits the practical instructions that determine whether the medicine works: how and when to take it relative to food, how to use the device (inhaler, nasal spray, eye drops, suppository), what to do after a missed dose, how to store it, and what to do with leftovers. The answer reads like a drug monograph, not a conversation with a patient.
Counselling is treated as soft content and revised last, if at all. Candidates also write in an academic register because that is how the rest of the exam is answered, and they forget that the assessed skill is transfer of information to a layperson. Device technique in particular is rarely practised hands-on.
What to do instead
Use a fixed counselling skeleton for every practice answer: what it is for, how and when to take it, how to use the device, what to expect and what side effects to report, missed-dose rule, storage, and follow-up. Practise explaining one inhaler and one eye-drop regimen in plain language without jargon, then check against the skeleton. Include the Greek-language patient leaflet structure (οδηγίες χρήσης) as a reference for what patients are actually told.
On legislation and ethics questions, the candidate answers from general principle ('the pharmacist must act in the patient's interest') instead of citing the specific Greek rule: prescription validity and retention periods, which medicines are prescription-only versus over-the-counter, narcotic and psychotropic record-keeping and special prescription forms, substitution and generic dispensing rules, advertising restrictions, and professional confidentiality obligations.
Legislation is perceived as dry and is deferred, so the candidate retains the ethical spirit but not the operative numbers and categories. Greek pharmacy law is layered (national transposition of EU directives plus national presidential decrees and ministerial decisions), and candidates confuse the layer that governs a given question. Vague answers lose marks even when the ethical instinct is right.
What to do instead
Build a legislation fact sheet organized by scenario rather than by statute: dispensing a prescription, dispensing a narcotic, substituting a generic, refusing to dispense, reporting an adverse reaction, advertising, and record retention. For each, write the rule, the time period, and the document that must be kept. Revise the sheet weekly and test yourself by scenario, not by reciting article numbers.
In pharmacovigilance questions, the candidate reports only 'obvious' serious reactions, misses the reporting obligation for suspected reactions to vaccines or for lack of efficacy, confuses the roles of the marketing authorization holder and the national competent authority, and cannot describe what a periodic safety update report or a signal actually is.
Pharmacovigilance is taught as a definition ('report adverse reactions') rather than as a workflow with actors, timelines, and document types. Candidates also assume reporting is limited to proven causality, when the standard is suspicion. Because Greece has a national reporting system routed through the EOF, candidates who have not seen the workflow cannot describe who sends what to whom and by when.
What to do instead
Map the workflow on one page: patient/clinician → pharmacist or physician report → national competent authority (EOF) and/or marketing authorization holder → EudraVigilance → signal detection → regulatory action. Annotate each arrow with the timeline and the form used. Then learn the definitions precisely (adverse event, adverse reaction, serious, suspected, signal, periodic safety update report) and practise classifying five short scenarios as reportable or not, with justification.
When a question requires integrating biochemistry or physiology with a disease state, the candidate recites the pathway or the normal value in isolation and cannot explain the pathophysiological link - for example, naming the urea cycle without explaining why hepatic failure raises ammonia and causes encephalopathy, or naming insulin without explaining the mechanism of diabetic ketoacidosis.
Biochemistry and physiology are revised as standalone subjects early in preparation and are not revisited once pharmacotherapy revision begins. The candidate therefore has facts but no causal chains, and integrated questions that bridge basic science to clinical consequence expose the gap. These questions are disproportionately common in the Greek licensing exam because they test whether the graduate can reason from first principles.
What to do instead
For each major disease state write a one-page causal chain from molecule to symptom: normal pathway → the specific lesion → the accumulated or deficient metabolite → the clinical sign → the drug target that corrects it. Cover at minimum diabetes and ketoacidosis, hepatic failure and encephalopathy, renal failure and electrolyte handling, thyroid disorders, atherosclerosis, and acid–base disorders. Test yourself by starting from the clinical sign and working backwards.